Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HCl in healthy subjects: Single-dose studies by the intravenous, intramuscular, and oral routes

H. G. Boxenbaum, K. A. Geitner, M. L. Jack, W. R. Dixon, H. E. Spiegel, J. Symington, R. Christian, J. D. Moore, L. Weissman and S. A. Kaplan

View Related Documents

Abstract

Single 30- mg doses of chlordiazepoxide HCl were administered to six healthy human subjects by the intravenous, oral, and intramuscular routes. Plasma concentration- time curves following intravenous administration were satisfactorily described by a biexponential equation consistent with a two-compartment open model system. Mean values of half-lives for the so-called distribution and elimination phases were 0.252 and 9.39 hr, respectively. The mean values for the volume of the central compartment (V 1) and volume of distribution (Vdb )(V_{d_\beta } ) were 18.0 and 30.9% of body weight, respectively. Following oral administration, the drug was rapidly and completely absorbed. Absorption was first order (t1/2ap27 min), and three of the six subjects showed a discernible lag time of approximately 20 min. Drug absorption following intramuscular administration was comparatively slow. A two- compartment ldquomuscle modelrdquo comprised of precipitated and solubilized drug in the muscle was found to satisfactorily characterize the absorption process following administration by this route.

Key words  chlordiazepoxide - benzodiazepine - two-compartment model, biopharmaceutics - pharmacokinetics - single dose - routes of administration - intravenous - intramuscular - oral

Fulltext Preview

Image of the first page of the fulltext document